Despite its potential, asymmetric catalysis via MHAT has remained a formidable challenge. Central to this difficulty is the inherently weak interaction between transient prochiral organic radicals and chiral catalysts. Radical species are often fleeting and poorly controlled, complicating efforts to induce enantioselectivity—control over the spatial arrangement of atoms that defines a molecule’s three-dimensional shape and its biological activity. Overcoming these limitations is pivotal, as asymmetric radical processes can unlock pathways to enantioenriched products highly valued in pharmaceuticals and agrochemicals.

Addressing this gap, a recent breakthrough harnesses the versatility of cytochrome P450 enzymes (CYPs)—nature’s own catalysts known for their versatile oxidative transformations. Recognized chiefly for their ability to activate molecular oxygen and perform selective oxidations, certain CYPs have now been repurposed to catalyze MHAT, a reaction that does not naturally occur in biological systems. This pioneering endeavor employed directed evolution, a technique that mimics natural selection in the laboratory to iteratively improve enzyme performance. Starting with a variant of the P450_BM3 enzyme, researchers developed a triple mutant capable of performing radical cyclizations on unactivated alkenes with remarkable stereocontrol.

The evolved P450_BM3 mutant demonstrated the ability to catalyze MHAT radical cyclization reactions that forge diverse cyclic amines such as pyrrolidines and piperidines—structural motifs frequently encountered in bioactive molecules. These transformations were achieved under aerobic whole-cell conditions, highlighting the practicality and robustness of the biocatalytic system. Strikingly, the reactions produced enantiomeric ratios as high as 98:2, signifying exceptional control over the stereochemical outcome and marking a notable advance in asymmetric radical chemistry.

Beyond substrates with electron-deficient alkenes, the repurposed enzymes expanded their substrate scope to include alternative radical acceptors such as hydrazones, oximes, and nitriles. This breadth underscores the enzyme’s adaptability and the potential for broad application in synthesizing structurally diverse heterocycles. The integration of these unconventional radical acceptors suggests new strategic avenues for assembling complex architectures in synthetic chemistry, combining the power of enzymatic precision with radical reactivity.

Mechanistic investigations into the catalytic cycle revealed that the enzyme operates through an MHAT pathway initiated by homolytic cleavage of a transient iron(III)–hydride intermediate. This fleeting species is central to the reaction, mediating hydrogen atom transfer to initiate radical formation. The homolytic cleavage contrasts with the more common heterolytic mechanisms of metal–hydride species and opens new mechanistic spaces that enzymes can exploit. These mechanistic insights also provide a blueprint for further engineering of enzymes tailored for radical transformations, guided by understanding how metalloenzymes can harness homolytic metal–hydride chemistry.

A testament to the power of directed evolution, starting from a different cytochrome P450 scaffold—CYP119—researchers evolved a stereocomplementary MHATase that delivers the opposite enantiomeric product with equally high selectivity. This stereocomplementarity showcases the tunability of enzymatic systems through iterative mutation and selection, enabling fine control over stereochemical outcomes and expanding practical synthetic capabilities. The availability of two complementary enzymes offers synthetic chemists versatile tools for stereodivergent synthesis, an essential aspect of drug discovery and development.

This groundbreaking work exemplifies how the natural versatility of metalloenzymes can be expanded by engineering novel reactivities, extending beyond their canonical functionalities. By integrating homolytic metal–hydride reactivity into biocatalysts, this study charts a course toward a new class of asymmetric radical biocatalysts. Such catalysts could revolutionize synthetic strategies by marrying the selectivity and sustainability of enzymatic approaches with the expansive reaction space accessible via radical intermediates.

The implications of this discovery extend beyond academic curiosity. Enzymatic MHAT catalysis has the potential to transform synthetic routes to chiral nitrogen heterocycles, privileged motifs in medicinal chemistry. The mild reaction conditions, use of whole-cell catalysts, and high stereoselectivity promise greener, more efficient synthetic processes that could supplant harsher traditional methods relying on metal complexes or radical initiators. Moreover, the ability to perform late-stage functionalizations on complex molecules opens doors to rapid diversification of pharmaceuticals and natural products.

Future avenues of research include expanding substrate scope to even more challenging alkenes and radical acceptors, optimizing enzyme stability and turnover in industrial settings, and combining MHAT biocatalysis with other enzymatic or chemical transformations in cascade sequences. Such integrated approaches could enable streamlined syntheses of molecules with dense stereochemical information, tackling synthetic challenges that have long stymied chemists.

Overall, this landmark study underscores a paradigm shift in asymmetric catalysis, where the power of radical intermediates traditionally constrained by lack of selectivity is now harnessed with exquisite control via engineered enzymes. It demonstrates the promise of melding bioinspiration with chemical innovation to unlock new frontiers in molecular synthesis.

As the toolkit of biocatalysis expands with innovative MHATases, synthetic chemists stand at the cusp of a radical revolution—one where enzymes not only mimic but also transcend natural capabilities to access previously elusive chemical space. In this dynamic interplay of radical chemistry and enzyme engineering, the future of asymmetric synthesis gleams brightly.

Subject of Research: Repurposing cytochrome P450 enzymes to catalyze asymmetric metal-hydride hydrogen atom transfer (MHAT) for radical hydrofunctionalization of unactivated alkenes.

Article Title: Repurposing haemoproteins for asymmetric metal-catalysed H atom transfer.

Article References:
Zhang, X., Chen, D., Álvarez, M. et al. Repurposing haemoproteins for asymmetric metal-catalysed H atom transfer. Nature (2025). https://doi.org/10.1038/s41586-025-09308-0

Image Credits: AI Generated

A groundbreaking study led by Yu, Huang, Zhang, and their colleagues has now pushed the frontiers of DKR beyond conventional boundaries by introducing an adaptive dynamic kinetic resolution strategy that is not only highly efficient but astonishingly versatile. Published recently in Nature Chemistry, this innovative methodology reshapes expectations for stereochemical control in catalytic processes by harnessing the dynamic interconversion of diastereomeric aminoalkyl cyclopalladated complexes. This subtle yet profound mechanistic innovation enables the selective formation of diverse azapolycyclic products with remarkable stereochemical fidelity.

At the heart of this advance is the realization that the absolute configurations of contiguous stereocenters can be modulated adaptively within the same chiral catalyst system merely by altering the ring sizes of the annulation products. This is a stunning departure from classical paradigms where the chiral catalyst’s inherent stereochemistry rigidly defines the stereochemical identity of products. Here, the dynamic nature of cyclopalladated intermediates — capable of existing as interconverting diastereomers — permits a flexible chirality induction landscape that can be tuned via subtle structural parameters in the substrate and product frameworks.

The synthetic utility of the adaptive DKR approach is underscored by its application to the facile construction of highly intricate azapolycycles, molecular architectures known for their prevalence in bioactive natural products and pharmaceuticals. The team demonstrated that controlling ring size effectively toggled the configuration of multiple stereocenters in the formed polycyclic scaffolds while retaining excellent enantio- and diastereoselectivities. This level of stereochemical control achieved through a singular catalytic system marks a paradigmatic shift in asymmetric catalysis, offering chemists a new dimension of stereochemical manipulation hitherto unavailable.

From a mechanistic standpoint, the pioneering work delves deeply into the nature of the cyclopalladated intermediates involved in the annulation processes. These metallacycles, ligated by chiral diphosphine palladium catalysts, exhibit dynamic equilibria between diastereomeric forms that interconvert under reaction conditions. The investigation involved comprehensive spectroscopic analyses alongside computational modeling to elucidate the energy landscapes governing these equilibria. Such insights revealed that the relative stabilities and interconversion rates of the aminoalkyl palladium species are highly sensitive to ring strain and conformational factors imposed by the annulation pathway.

The implications are profound: by tuning the substrate architecture to favor certain diastereomeric intermediates, the palladium catalyst’s chiral environment can be ‘adapted’ in situ to induce either of two absolute configurations in the product, all while using the very same ligand. This dynamic adaptability represents a conceptual leap, merging the often rigid world of asymmetric catalysis with the fluid dynamics of stereochemical equilibria to unlock previously inaccessible synthetic possibilities.

Moreover, the synthetic potential of this strategy is dramatically showcased in the total synthesis of martinellic acid, an alkaloid natural product possessing a complex polycyclic framework decorated with multiple contiguous stereocenters. The research team employed the adaptive DKR as a pivotal step to forge the key chiral scaffold, efficiently establishing the stereochemical array intrinsic to martinellic acid. This strategic integration not only validates the methodology’s practicality but also highlights its capacity to streamline complex molecule assembly by reducing the number of discrete stereochemical manipulation steps typically required.

Importantly, this approach addresses longstanding challenges in asymmetric synthesis where different absolute configurations at adjacent stereocenters often require distinct catalysts or reaction conditions. Here, the same catalytic system can adapt to diverse stereochemical demands simply through substrate design and ring size modulation, greatly simplifying synthetic workflows. Such versatility promises to accelerate the discovery and production of complex chiral molecules in medicinal chemistry and materials science.

Further investigations within the study explored the scope of the adaptive DKR process, demonstrating broad tolerance for various functional groups and substitution patterns. The methodology proved robust across an array of substrates, consistently generating azapolycycles with high stereochemical integrity. This robustness reflects the generality of the dynamic interconversion phenomenon underpinning the system, reinforcing its potential as a foundational tool in asymmetric catalysis.

Critically, the research also provides a window into the delicate balance between kinetic and thermodynamic factors in determining stereochemical outcomes under dynamic catalytic conditions. The equilibrium behaviors of palladacyclic intermediates, coupled with rate-enhancing ring closure steps, orchestrate the interplay of stereochemical pathways to favor one configuration or another depending on molecular context. This nuanced choreography, elegantly rationalized by the team’s combined experimental and computational approach, offers a valuable framework for the rational design of future adaptive catalytic processes.

The use of chiral diphosphine ligands in this system serves dual roles: stabilizing the palladium center and creating a chiral pocket that mediates substrate binding and transformation. The interplay of ligand bite angle, electronic effects, and steric environment contributes to the fine-tuning of dynamic equilibria among palladium complexes. Modulating these parameters alongside substrate structural features could open further avenues for controlling stereoselectivity dynamically, expanding the conceptual reach of adaptive catalysis.

Understanding the fundamental principles of dynamic kinetic resolution has been critical in guiding this breakthrough. Traditional DKR requires the separate but concurrent processes of racemization and selective reaction — balancing rates to achieve full conversion without loss of enantioselectivity. The adaptive strategy propels this concept forward by embedding flexibility within the kinetic resolution step itself, leveraging reversible metallacycle diastereomerism to achieve configurational switching. It is a paradigm that elegantly unites kinetics, thermodynamics, and stereochemistry.

Beyond its immediate synthetic applications, this discovery throws open the doors to a new class of catalytic systems capable of ‘chiral adaptation’ in response to subtle structural cues. Such systems could potentially revolutionize asymmetric catalysis by introducing dynamic switchability into chirality control, enabling molecules with tailored stereochemical arrangements from common catalytic frameworks. This might lead to more sustainable and efficient processes, reducing the need for multiple catalyst screenings and specialized ligand development.

While the current study focuses on palladium-based systems and azapolycyclic frameworks, the underlying principles of diastereomeric interconversion and ring size-mediated induction could inspire analogous approaches in other metal-catalyzed transformations. The scope for exploiting metallacycle dynamics and substrate conformational effects to fine-tune stereochemical outcomes offers fertile ground for future research at the interface of organometallic chemistry and asymmetric synthesis.

In conclusion, the work by Yu and co-workers marks a significant milestone in the evolution of chiral catalysis. The adaptive dynamic kinetic resolution they describe heralds a future where the stereochemical destiny of synthetic molecules can be dynamically tailored without changing the fundamental catalytic architecture. By deftly wielding the dynamic equilibria of cyclopalladated complexes, this strategy injects unprecedented flexibility and precision into the control of contiguous stereocenters, opening exciting vistas in complex molecule construction and catalytic design.

As chemists continue to seek more elegant, efficient, and versatile methods to forge chiral complexity, innovations like this adaptive DKR blueprint illuminate the path forward. Their ability to finely tune stereochemical outcomes through a harmonious interplay of dynamic catalysis and substrate engineering promises to deepen our mastery over molecular architecture, ultimately translating into advances in pharmaceuticals, agrochemicals, and advanced materials with unprecedented structural sophistication.

Subject of Research: Adaptive dynamic kinetic resolution in asymmetric catalysis and stereocontrol of azapolycycles via cyclopalladated intermediates.

Article Title: Adaptive dynamic kinetic resolution enables alteration of chiral induction with ring sizes.

Article References:
Yu, B., Huang, Y., Zhang, H. et al. Adaptive dynamic kinetic resolution enables alteration of chiral induction with ring sizes. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01850-8

Image Credits: AI Generated